Rapid Diagnosis of Severe Respiratory Tract Infectious Diseases and Screening of Biomarkers for Stratified Diagnosis

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorChinese PLA General Hospital

About this trial

The purpose of this study is to clarify the biomarkers for rapid diagnosis and stratified diagnosis of severe respiratory tract infectious diseases through clinical experiments.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Meets the diagnostic criteria for severe pneumonia;

Age≥18 years old and < 80 years old;

Willing to sign informed consent for the course of the study;

Disqualifiers

Patients with intracranial hypertension, acute coronary syndrome, pleural fistula, pneumothorax, or subcutaneous emphysema;

Pregnant and lactating patients;

Severely hemodynamically unstable (an increase in vasopressors by more than 30% in the first 6 hours, or norepinephrine >0.5mg/kg/min);

Those who do not consent to participate in this study;

Trial population

Meets the diagnostic criteria for severe pneumonia;

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

100 Participants
are grouped into 3 trial groups
Group A: mild
Group B: moderate
Group C: severe

Trial outcomes

Primary outcomes

1

The relationship between the patient's specific biomarker levels and clinical outcomes.

Treatment failure rate, Mortality rates, SOFA rating scale

Time frame
1 mounth

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: